Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma

Biomaterials

Volumn 35, Issue 21, 2014, Pages 5591-5604

  Li, Xiu Ying ^a   Zhao, Yao ^a   Sun, Meng Ge ^a   Shi, Ji Feng ^a   Ju, Rui Jun ^a   Zhang, Cheng Xiang ^a   Li, Xue Tao ^a   Zhao, Wei Yu ^a   Mu, Li Min ^a   Zeng, Fan ^a   Lou, Jin Ning ^b   Lu, Wan Liang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Anticancer efficacy; Brain glioma; Cancer stem cells; Functional targeting liposomes; VM channels

Indexed keywords

CELL DEATH; CHEMOTHERAPY; DIAGNOSIS; DISEASES; FUNCTIONAL MATERIALS; LIPOSOMES; MOLECULAR BIOLOGY; PROTEINS; STEM CELLS; SURGERY;

ANTI-APOPTOTIC PROTEIN; ANTICANCER EFFICACY; BLOOD-BRAIN BARRIER; BRAIN GLIOMATA; CANCER STEM CELLS; GLUCOSE TRANSPORTERS; RECEPTOR-MEDIATED ENDOCYTOSIS; VM CHANNELS;

TUMORS;

ALPHA TOCOPHEROL; ARTEMETHER; DEQUALINIUM; DISTEAROYPHOSPHATIDYL ETHANOLAMINE; GLUCOSE TRANSPORTER; LIPID; LIPOSOME; MACROGOL 2000; MANNOSE; PACLITAXEL; UNCLASSIFIED DRUG; 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE-N-METHOXY-POLY(ETHYLENE GLYCOL 2000); ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE; MACROGOL DERIVATIVE; PHOSPHATIDYLETHANOLAMINE;

ADSORPTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CANCER VASCULOGENIC MIMICRY; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG MECHANISM; DRUG TRANSPORT; ENDOCYTOSIS; GLIOMA; GLIOMA CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR INVASION; ANIMAL; BRAIN; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEM; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; DEQUALINIUM; DRUG DELIVERY SYSTEMS; GLIOMA; LIPOSOMES; MALE; MANNOSE; MICE; MICE, INBRED ICR; PACLITAXEL; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 84899485459     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.03.049     Document Type: Article

References (34)

1. Wrensch M., Minn Y., Chew T., Bondy M., Berger M.S. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002, 4:278-299.
2. Behin A., Hoang-Xuan K., Carpentier A.F., Delattre J.Y. Primary brain tumours in adults. Lancet 2003, 361:323-331.
3. Weil R.J., Palmieri D.C., Bronder J.L., Stark A.M., Steeg P.S. Breast cancer metastasis to the central nervous system. Am J Pathol 2005, 167:913-920.
4. Agarwal S., Sane R., Oberoi R., Ohlfest J.R., Elmquist W.F. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med 2011, 13:13-17.
5. Yan H., Wang J., Yi P., Lei H., Zhan C., Xie C., et al. Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chem Commun (Camb) 2011, 47:8130-8132.
6. Pardridge W.M. BBB-Genomics: creating new openings for brain-drug targeting. Drug Discov Today 2001, 6:381-383.
7. Vescovi A.L., Galli R., Reynolds B.A. Brain tumour stem cells. Nat Rev Cancer 2006, 6:425-436.
8. Zhang S., Zhang D., Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett 2007, 254:157-164.
9. Zhang L., Yao H.J., Yu Y., Zhang Y., Li R.J., Ju R.J., et al. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells. Biomaterials 2012, 33:565-582.
10. Ying X., Wen H., Lu W.L., Du J., Guo J., Tian W., et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. JControl Release 2010, 141:183-192.
11. Zhan C., Gu B., Xie C., Li J., Liu Y., Lu W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. JControl Release 2010, 143:136-142.
12. Postma T.J., Heimans J.J., Luykx S.A., Groeningen C.J., Beenen L.F., Hoekstra O.S., et al. Aphase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma. Ann Oncol 2000, 11:409-413.
13. Hien T.T., White N.J. Qinghaosu. Lancet 1993, 341:603-608.
14. Nakase I., Lai H., Singh N.P., Sasaki T. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation. Int J Pharm 2008, 345:28-33.
15. Anfosso L., Efferth T., Albini A., Pfeffer U. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J 2006, 6:269-278.
16. Wartenberg M., Wolf S., Budde P., Grünheck F., Acker H., Hescheler J., et al. The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. Lab Invest 2003, 83:1647-1655.
17. Zhou X.D., Wang X.Y., Qu F.J., Zhong Y.H., Lu X.D., Zhao P., et al. Detection of cancer stem cells from the C6 glioma cell line. JInt Med Res 2009, 37:503-510.
18. Wang X.X., Li Y.B., Yao H.J., Ju R.J., Zhang Y., Li R.J., et al. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 2011, 32:5673-5687.
19. Vermeulen P.B., Golen K.L., Dirix L.Y. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer 2010, 116:2748-2754.
20. Zhang Y., Li R.J., Ying X., Tian W., Yao H.J., Men Y., et al. Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer. Mol Pharmacol 2011, 8:162-175.
21. Ojima I. Modern molecular approaches to drug design and discovery. Acc Chem Res 2008, 41:2-3.
22. Pardridge W.M. Blood-brain barrier delivery. Drug Discov Today 2007, 12:54-61.
23. Gorin F., Harley W., Schnier J., Lyeth B., Jue T. Perinecrotic glioma proliferation and metabolic profi{ligature}le within an intracerebral tumor xenograft. Acta Neuropathol 2004, 107:235-244.
24. Zhou J., Zhao W.Y., Ma X., Ju R.J., Li X.Y., Li N., et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Biomaterials 2013, 34:3626-3638.
25. Mi Y., Liu Y., Feng S.S. Formulation of docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 2011, 32:4058-4066.
26. Bickel U., Yoshikawa T., Pardridge W.M. Delivery of peptides and proteins through the blood-brain barrier. [Review]. Adv Drug Deliv Rev 2001, 46:247-279.
27. Ma X., Zhou J., Zhang C.X., Li X.Y., Li N., Ju' R.J., et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials 2013, 34:4452-4465.
28. Li N., Zhang C.X., Wang X.X., Zhang L., Ma X., Zhou J., et al. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Biomaterials 2013, 34:3366-3380.
29. Brahimi-Horn M.C., Chiche J., Pouysségur J. Hypoxia and cancer. JMol Med Berl 2007, 85:1301-1307.
30. Lirdprapamongkol K., Chiablaem K., Sila-Asna M., Surarit R., Bunyaratvej A., Svasti J. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2012, 422:429-435.
31. Angulo J.C., Ferruelo A., Rodríguez-Barbero J.M., Núñez C., Fata F.R., González J. Detection and molecular staging of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9) and TIMP-2 in peripheral blood. Actas Urol Esp 2011, 35:127-136.
32. Hess A.R., Seftor E.A., Seftor R.E., Hendrix M.J. Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 2003, 63:4757-4762.
33. Giatromanolaki A., Koukourakis M.I., Sivridis E., Turley H., Talks K., Pezzella F., et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 2001, 85:881-890.
34. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 2003, 100:15178-15183.